UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
40 hedge funds and large institutions have $6.87M invested in Unity Biotechnology in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 46 → 40 (-6)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Holders
40
Holding in Top 10
3
Calls
$4.08M
Puts
$70K
Top Buyers
| 1 | +$111K | |
| 2 | +$99.5K | |
| 3 | +$46K | |
| 4 |
PCIA
Prime Capital Investment Advisors
Overland Park,
Kansas
|
+$29.1K |
| 5 |
BlackRock
New York
|
+$18.7K |
Top Sellers
| 1 | -$720K | |
| 2 | -$153K | |
| 3 | -$142K | |
| 4 |
Renaissance Technologies
New York
|
-$89K |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$86.6K |